Myelodysplastic Syndrome (RAEB-II) Development 2 Months after Chemotherapy for a Primary Non-seminomatous Mediastinal Germ Cell Tumor / 대한내과학회지
Korean Journal of Medicine
;
: 460-463, 2016.
Artículo
en Inglés
| WPRIM
| ID: wpr-101313
ABSTRACT
Here, we report on a 20-year-old patient with a primary nonseminomatous mediastinal germ cell tumor (MGCT) who developed myelodysplastic syndrome (MDS) 2 months following chemotherapy with cisplatin, etoposide, ifosfamide, and paclitaxel. Bone marrow examinations revealed that the MDS was a refractory anemia with excess type II blasts and complex chromosomal abnormalities. With the onset of MDS occurring rapidly following chemotherapy, it is unlikely to have been caused by the therapy. We discuss the association between primary nonseminomatous MGCTs and hematological malignancies, including the possibility of a common clonal origin.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Examen de la Médula Ósea
/
Síndromes Mielodisplásicos
/
Anemia Refractaria
/
Aberraciones Cromosómicas
/
Cisplatino
/
Paclitaxel
/
Neoplasias de Células Germinales y Embrionarias
/
Neoplasias Hematológicas
/
Quimioterapia
/
Etopósido
Límite:
Humanos
Idioma:
Inglés
Revista:
Korean Journal of Medicine
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS